$DVA reported 1Q16 operating income of $422MM. Normalized non-acquired growth was 4.1%, consistent with guidance of 3.5-4.5%. Rate per treatment rose by $2.34 per treatment, mainly driven by higher acute mix and improved commercial mix.
$IART said that a tender offer by its subsidiary Integra Derma to buy all outstanding common and preferred shares of $DSCI at an offer price of $7.00 per common share, $32.00 per Series A Convertible Preferred share and $48.00 per Series B Convertible Preferred share, expired as scheduled on Feb. 22, 2017.
$TNC agreed with private equity fund Ambienta to buy IPC Group, a privately-held designer and manufacturer of commercial cleaning solutions based in Italy, in an all-cash transaction valued at about $350MM. $TNC expects the acquisition to be accretive to 2018 EPS. $TNC expects the acquisition to be completed in the 2Q17.